Study number 8530-848
Dates
Jun 24 2024-Nov 30 2024
Location
Madison, Wisconsin
Age
18-65
Gender
Male or Female
Smoker
Compensation
$15,021
Group
E1 or E2
The investigational drug in this research study is being developed for the treatment of obesity.
The purposes of this study are to look at:
• How well the study drugs are tolerated and any side effects of the study drugs
• The effect of the study drugs on body weight
• How much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given with tirzepatide. Tirzepatide is an investigational drug that has been approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management. The use of tirzepatide in this study is investigational.
Fortrea Madison, WI is recruiting for:
- Healthy Overweight Men and Women, age 18-65
- Body Mass Index between 27-45
- Study involves multiple overnight stays & outpatient visits
- Compensation up to $15,021 may be provided for time and participation
- Refer a friend to receive $300 per qualified referral
Call Now To Schedule Your Screening Appointment!
Group E1:
Check-In: Jun 24
Check-Out: Jun 29
Check-In: Jul 2
Check-Out: Jul 3
Check-In: Jul 9
Check-Out: Jul 10
Check-In: Jul 16
Check-Out: Jul 17
Check-In: Jul 23
Check-Out: Jul 24
Check-In: Jul 30
Check-Out: Jul 31
Check-In: Aug 6
Check-Out: Aug 7
Check-In: Aug 13
Check-Out: Aug 14
Check-In: Aug 20
Check-Out: Aug 21
Check-In: Aug 27
Check-Out: Aug 28
Check-In: Sep 3
Check-Out: Sep 4
Check-In: Sep 10
Check-Out: Sep 14
Follow up Visits: Oct 5, 19, Nov 2, 16, 30
Group E2:
Check-In: Jul 16
Check-Out: Jul 21
Check-In: Jul 24
Check-Out: Jul 25
Check-In: Jul 31
Check-Out: Aug 1
Check-In: Aug 7
Check-Out: Aug 8
Check-In: Aug 14
Check-Out: Aug 15
Check-In: Aug 21
Check-Out: Aug 22
Check-In: Aug 28
Check-Out: Aug 29
Check-In: Sep 4
Check-Out: Sep 5
Check-In: Sep 11
Check-Out: Sep 12
Check-In: Sep 18
Check-Out: Sep 19
Check-In: Sep 25
Check-Out: Sep 26
Check-In: Oct 2
Check-Out: Oct 6
Follow up Visits: Oct 27, Nov 10, 24, Dec 8, 22